Torrent Pharma’s ₹25,689-crore acquisition of JB Chemicals boosts its chronic portfolio and expands its global reach. But ...

The acquisition involves Torrent Pharma buying a 46.39 per cent stake from global investment firm KKR and an additional 2.8 ...

Jefferies issues Buy ratings on Polycab, Torrent Pharma, and Ambuja Cements with up to 22% return potential - see if these stocks fit your portfolio!

Torrent Pharmaceutical Ltd. will buy J. B. Chemicals and Pharmaceuticals Ltd. (JB Pharma) from private equity firm KKR & Co.

Find insight on Torrent Pharmaceuticals, Healius, Sonic Healthcare, and more in the latest Market Talks covering Health Care.

KKR sold off its 46.39% stake in J.B. Chemicals and Pharmaceuticals to Torrent Pharma after grooming the Indian drugmaker ...

Torrent Pharmaceuticals aims to complete the acquisition of a majority stake in JB Chemicals for Rs 19,500 crore, bolstering its presence in the Indian pharmaceutical market. The merger offers ...

The deal grants Torrent Pharma access to a thriving pharmaceutical business. JB Pharma makes drugs for gastroenterology, ...

India's Torrent Pharmaceuticals said on Sunday it will acquire a 46.39% controlling stake in smaller peer JB Chemicals and Pharmaceuticals from New York-based investment firm KKR , and plans to merge ...

Torrent Pharmaceuticals will acquire a 46.39% stake in JB Chemicals and Pharmaceuticals from New York's KKR, intending to merge the two companies. The acquisition values JB Pharma at 256.89 billion ...

JB Chemicals shares fell 6.52 per cent to hit a low of Rs 1,681.90. The Torrent Pharmaceuticals stock, on the other hand, was ...